| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
153,922,000 |
| Market
Cap: |
6.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$36.9 - $39.95 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
40,000 |
561,286 |
| Total Sell Value |
$0 |
$0 |
$1,546,400 |
$15,378,126 |
| Total People Sold |
0 |
0 |
1 |
5 |
| Total Sell Transactions |
0 |
0 |
2 |
30 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Patel Samir Chandrakant |
President |
• • – |
2015-09-21 |
4 |
OE |
$1.65 |
$206,751 |
D/D |
27,215 |
286,507 |
|
- |
|
| Bjarke Henric Bjorn |
SVP & CCOOfficer |
• – – |
2015-08-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
300 |
|
- |
|
| Bjarke Henric Bjorn |
SVP & CCOOfficer |
• – – |
2015-08-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-08-31 |
4 |
AS |
$44.54 |
$834,050 |
D/D |
(18,582) |
29,910 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-08-31 |
4 |
OE |
$10.03 |
$186,377 |
D/D |
18,582 |
48,492 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2015-08-20 |
4 |
AS |
$47.80 |
$1,326,597 |
D/D |
(27,215) |
259,292 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2015-08-20 |
4 |
OE |
$1.65 |
$44,959 |
D/D |
27,215 |
286,507 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-08-07 |
4 |
OE |
$10.03 |
$299,997 |
D/D |
29,910 |
29,910 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-07-30 |
4 |
AS |
$65.79 |
$1,232,417 |
D/D |
(18,582) |
0 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-07-30 |
4 |
OE |
$10.03 |
$186,377 |
D/D |
18,582 |
18,582 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2015-07-20 |
4 |
AS |
$67.26 |
$1,847,037 |
D/D |
(27,215) |
259,292 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2015-07-20 |
4 |
OE |
$1.65 |
$44,959 |
D/D |
27,215 |
286,507 |
|
- |
|
| Sblendorio Glenn |
Director |
– • – |
2015-07-17 |
4 |
AS |
$70.00 |
$140,000 |
D/D |
(2,000) |
0 |
|
- |
|
| Sblendorio Glenn |
Director |
– • – |
2015-07-17 |
4 |
OE |
$13.22 |
$26,432 |
D/D |
2,000 |
2,000 |
|
- |
|
| Sblendorio Glenn |
Director |
– • – |
2015-07-16 |
4 |
AS |
$62.00 |
$62,000 |
D/D |
(1,000) |
0 |
|
- |
|
| Wood Barbara A |
SVP,General Counsel, Secretary |
• – – |
2015-07-01 |
4 |
AS |
$51.94 |
$103,880 |
D/D |
(2,000) |
0 |
|
- |
|
| Wood Barbara A |
SVP,General Counsel, Secretary |
• – – |
2015-07-01 |
4 |
OE |
$24.49 |
$48,980 |
D/D |
2,000 |
2,000 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-06-29 |
4 |
AS |
$50.71 |
$948,694 |
D/D |
(18,582) |
0 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-06-29 |
4 |
OE |
$10.03 |
$186,377 |
D/D |
18,582 |
18,582 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2015-06-19 |
4/A |
OE |
$1.59 |
$581,499 |
D/D |
259,292 |
259,292 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2015-06-19 |
4 |
OE |
$1.59 |
$581,499 |
D/D |
259,292 |
14,331 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2015-06-18 |
4 |
AS |
$49.60 |
$597,306 |
D/D |
(12,000) |
0 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2015-06-18 |
4 |
OE |
$1.59 |
$19,262 |
D/D |
12,000 |
2,471 |
|
- |
|
| Galakatos Nicholas |
Director |
– • – |
2015-06-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,020 |
14,184 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2015-05-28 |
4 |
AS |
$47.40 |
$903,516 |
D/D |
(18,582) |
0 |
|
- |
|
468 Records found
|
|
Page 15 of 19 |
|
|
